Britain Puts $10 Million Into Study on Long Term Effects of COVID-19 - COVID-19 Clinical Trial
Breaking News | COVID-19

Britain Puts $10 Million Into Study on Long Term Effects of COVID-19

 Britain is putting 8.4 million pounds into a new study to examine the long-term effects of COVID-19 on patients, the health ministry said on Sunday. The novel coronavirus which causes COVID-19 has been observed to cause many health impacts for some patients beyond immediate respiratory issues, but with other infected people asymptomatic, the workings of the virus are not fully understood.

“As we continue our fight against this global pandemic, we are learning more and more about the impact the disease can have, not only on immediate health but longer-term physical and mental health too,” health minister Matt Hancock said. The Department of Health said 10,000 people would take part in the study, which is being led by the University of Leicester and hospitals in the city.


Tesla to Make Polecule Printers for COVID-19 Vaccine Developer CureVac

Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker’s Chief Executive Officer, Elon Musk, tweeted on Wednesday.CureVac, an unlisted German company, has said it is developing portable, automated mRNA production units that it calls printers and which Musk described as “RNA micro-factories”.

They are being designed to be shipped to remote locations, where they can churn out its vaccine candidate and other mRNA-based therapies depending on the recipe fed into the machine.But for the immediate pandemic use – should its vaccine candidate win market approval – it has production sites with regulatory approval in Germany with a capacity to produce hundreds of millions of doses.

Share this:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on reddit
Reddit
Share on email
Email
Scroll to Top

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.